Free Trial

PharmChem Q4 2023 Earnings Report

$3.18 +0.02 (+0.71%)
As of 01/21/2025 02:55 PM Eastern

PharmChem EPS Results

Actual EPS
$0.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PharmChem Revenue Results

Actual Revenue
$1.40 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PharmChem Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

PharmChem Earnings Headlines

Cedar Creek Partners Q3 2024 Results
Please take this warning seriously...
I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days. In fact, I believe it could begin as soon as January 29th… Meaning you don’t have much time to prepare.
Cedar Creek Partners Q2 2024 Results
Getinge AB (publ) (GTN0.F)
PharmChem, Inc. (PCHM)
See More PharmChem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PharmChem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PharmChem and other key companies, straight to your email.

About PharmChem

PharmChem (OTCMKTS:PCHM) provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

View PharmChem Profile

More Earnings Resources from MarketBeat